Article
Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines
1 Sept 2010
Abstract excerpt
Abstract: Azacitidine (AZA) and decitabine (DAC) are cytidine azanucleoside analogs with clinical activity in myelodysplastic syndromes (MDS) and potential activity in solid tumors. To better understand the mechanism of action of these drugs, we examined the effects of AZA and DAC in a panel of non-small cell lung cancer (NSCLC) cell lines. Of 5 NSCLC lines tested in a cell viability assay, all were sensitive to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.